Exicure (XCUR) Capital Expenditures (2016 - 2025)

Exicure (XCUR) reported Capital Expenditures of -$213000.0 for Q4 2025, down 100.94% quarter-over-quarter from -$106000.0 in Q3 2025.

Exicure (XCUR) Capital Expenditures (2016 - 2025) Analysis & Trends

Exicure has reported Capital Expenditures for 8 years, with the latest figure at -$213000.0 in Q4 2025.

For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to -$213000.0; the trailing twelve-month figure through Dec 2025 stood at -$319000.0 (changed N/A YoY), and the FY2025 full-year result was $1000.0, changed N/A from the prior year.
Capital Expenditures for Q4 2025 stood at -$213000.0, down from -$106000.0 in the prior quarter.
The five-year high for Capital Expenditures was $345000.0 in Q4 2021, with the low at -$213000.0 in Q4 2025.
Historically, Capital Expenditures has averaged $82375.0 across 3 years, with a median of $32500.0 in 2021.
Annual changes were most pronounced in 2021 — Capital Expenditures surged 165.57% — and 2022, when it plunged 98.82%.
Exicure's Capital Expenditures stood at $345000.0 in 2021, then sank by 98.84% to $4000.0 in 2022, then sank by 5425.0% to -$213000.0 in 2025.
The last three Capital Expenditures figures came in at -$213000.0 (Q4 2025), -$106000.0 (Q3 2025), and $4000.0 (Q2 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	133.40 Mn
9	Abivax	94.37 Bn	94.37 Bn	-	-63,220.27
10	Exicure	19.38 Mn	16.77 Mn	-	-

Download Data